Home   >  
Angiogenesis/Protein Tyrosine Kinase
  >  
VDA

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products

Antibodies

Peptides

Catalysts

Impurities

Intermediate

Raw Materials

VDA

Chemical Structure Cat. No. Product Name CAS No.
Verubulin Chemical Structure
BCP09127 Verubulin 827031-83-4
Verubulin, Radiation Therapy, and Temozolomide to Treat Patients With Newly Diagnosed Glioblastoma Multiforme.
Ombrabulin Chemical Structure
BCP07754 Ombrabulin 181816-48-8
Ombrabulin is a synthetic water-soluble analogue of combretastatin A4, derived from the South African willow bush (Combretum caffrum), with potential vascular-disrupting and antineoplastic activities.
AZD-6126 Chemical Structure
BCP04084 AZD-6126 219923-05-4
AZD6126 was being investigated by AstraZeneca as a VDA (vascular disrupting agent).AZD-6126 is an angiogenesis inhibitor and tubulin inhibitor potentially for the treatment of solid tumours.
BNC105P Chemical Structure
BCP04200 BNC105P 945771-96-0
BNC105P is a benzofuran-based vascular disrupting agent (VDA) prodrug with potential anti-vascular and antineoplastic activities.
BNC105 Chemical Structure
BCP19547 BNC105 945771-74-4
BNC105 is a tubulin polymerization inhibitor with potent antiproliferative and tumor vascular disrupting properties.
Verteporfin Chemical Structure
BCP04238 Verteporfin 129497-78-5
Verteporfin, a benzoporphyrin derivative, is a medication used as a photosensitizer for photodynamic therapy.
Plinabulin Chemical Structure
BCP02849 Plinabulin 714272-27-2
NPI-2358 (Plinabulin) is a novel vascular disrupting agent (VDA) with an IC50 of 15 nM against HT-29 cells.
DMXAA Chemical Structure
BCP01949 DMXAA 117570-53-3
DMXAA is a vascular disrupting agents (VDA) and competitive inhibitor of DT-diaphorase with Ki of 20 μM and IC50 of 62.5 μM in cell-free assays, respectively.
0086-15971444841